top of page
  • Patient Education: Reading

Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.



Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.


Generic Revlimid

MARCH 07, 2022 - TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a first generic version of Revlimid®1 (lenalidomide capsules), in 5mg, 10mg, 15mg, and 25mg strengths, in the United States.



Label: LENALIDOMIDE capsule

Comments


Posts Archive
bottom of page